
iCAD Investor Relations Material
Latest events

Q3 2023
iCAD
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
iCAD, Inc. provides solutions that support radiation oncology specialists in their daily practice. Through a robust product portfolio, iCAD provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. These include its innovative 4D-Vantage™ platform, which allows radiation therapists to plan treatment based on a patient’s movement over time to preserve the patient’s healthy tissue while delivering high doses of radiation to the tumor. The company also offers image analysis and workflow solutions.
Latest articles

Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023

Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023

Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023
Ticker symbol
ICAD
Country
🇺🇸 United States